These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 9268605)
1. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Ehrich M; Correll L; Veronesi B Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters. Ehrich M; Correll L J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941 [TBL] [Abstract][Full Text] [Related]
3. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate. Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135 [TBL] [Abstract][Full Text] [Related]
4. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon. Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916 [TBL] [Abstract][Full Text] [Related]
5. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH). Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477 [TBL] [Abstract][Full Text] [Related]
6. Using neuroblastoma cell lines to address differential specificity to organophosphates. Ehrich M Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):291-2. PubMed ID: 7671443 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Ehrich M; Jortner BS; Padilla S Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. Barber D; Correll L; Ehrich M J Toxicol Environ Health A; 1999 May; 57(1):63-74. PubMed ID: 10321902 [TBL] [Abstract][Full Text] [Related]
9. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Ehrich M; Correll L; Veronesi B Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219 [TBL] [Abstract][Full Text] [Related]
10. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094 [TBL] [Abstract][Full Text] [Related]
11. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE). Sogorb MA; González-González I; Pamies D; Vilanova E Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283 [TBL] [Abstract][Full Text] [Related]
12. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE). Singh AK SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925 [TBL] [Abstract][Full Text] [Related]
13. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter. Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546 [TBL] [Abstract][Full Text] [Related]
14. Esterase comparison in neuroblastoma cells of human and rodent origin. Ehrich M; Veronesi B Clin Exp Pharmacol Physiol; 1995 May; 22(5):385-6. PubMed ID: 7554440 [TBL] [Abstract][Full Text] [Related]
15. High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells. Fernandes LS; Emerick GL; Ferreira RS; Santos NAGD; Santos ACD Toxicol In Vitro; 2017 Mar; 39():84-92. PubMed ID: 27939611 [TBL] [Abstract][Full Text] [Related]
16. Esterase inhibition in SH-SY5Y human neuroblastoma cells following exposure to organophosphorus compounds for 28 days. Barber DS; Ehrich M In Vitr Mol Toxicol; 2001; 14(2):129-35. PubMed ID: 11690566 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications. Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237 [TBL] [Abstract][Full Text] [Related]
18. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Kropp TJ; Richardson RJ J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540 [TBL] [Abstract][Full Text] [Related]
19. NTE soluble isoforms: new perspectives for targets of neuropathy inducers and promoters. Vilanova E; Escudero MA; Barril J Chem Biol Interact; 1999 May; 119-120():525-40. PubMed ID: 10421492 [TBL] [Abstract][Full Text] [Related]